American Century Companies’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.88M | Sell |
107,003
-387,818
| -78% | -$21.3M | ﹤0.01% | 1601 |
|
2025
Q1 | $35M | Sell |
494,821
-176,348
| -26% | -$12.5M | 0.02% | 774 |
|
2024
Q4 | $44.1M | Sell |
671,169
-53,019
| -7% | -$3.48M | 0.03% | 684 |
|
2024
Q3 | $50.9M | Sell |
724,188
-89,747
| -11% | -$6.31M | 0.03% | 601 |
|
2024
Q2 | $67M | Buy |
813,935
+120,023
| +17% | +$9.88M | 0.04% | 455 |
|
2024
Q1 | $60.6M | Buy |
693,912
+6,468
| +0.9% | +$565K | 0.04% | 481 |
|
2023
Q4 | $66.3M | Buy |
687,444
+161,157
| +31% | +$15.5M | 0.05% | 415 |
|
2023
Q3 | $46.6M | Buy |
526,287
+956
| +0.2% | +$84.6K | 0.04% | 481 |
|
2023
Q2 | $45.5M | Buy |
525,331
+496,016
| +1,692% | +$43M | 0.03% | 473 |
|
2023
Q1 | $2.85M | Buy |
29,315
+8,243
| +39% | +$801K | ﹤0.01% | 1477 |
|
2022
Q4 | $2.18M | Buy |
21,072
+4,977
| +31% | +$515K | ﹤0.01% | 1522 |
|
2022
Q3 | $1.36M | Buy |
16,095
+4,734
| +42% | +$401K | ﹤0.01% | 1581 |
|
2022
Q2 | $941K | Buy |
11,361
+49
| +0.4% | +$4.06K | ﹤0.01% | 1690 |
|
2022
Q1 | $872K | Buy |
11,312
+4,440
| +65% | +$342K | ﹤0.01% | 1723 |
|
2021
Q4 | $607K | Buy |
6,872
+640
| +10% | +$56.5K | ﹤0.01% | 1849 |
|
2021
Q3 | $482K | Buy |
6,232
+835
| +15% | +$64.6K | ﹤0.01% | 1892 |
|
2021
Q2 | $450K | Buy |
5,397
+1,326
| +33% | +$111K | ﹤0.01% | 1878 |
|
2021
Q1 | $307K | Buy |
+4,071
| New | +$307K | ﹤0.01% | 1912 |
|
2020
Q3 | – | Sell |
-1,776
| Closed | -$219K | – | 1808 |
|
2020
Q2 | $219K | Buy |
+1,776
| New | +$219K | ﹤0.01% | 1569 |
|
2019
Q3 | – | Sell |
-9,972
| Closed | -$854K | – | 1219 |
|
2019
Q2 | $854K | Sell |
9,972
-34,371
| -78% | -$2.94M | ﹤0.01% | 1100 |
|
2019
Q1 | $3.94M | Hold |
44,343
| – | – | ﹤0.01% | 865 |
|
2018
Q4 | $3.78M | Sell |
44,343
-5,741
| -11% | -$489K | ﹤0.01% | 869 |
|
2018
Q3 | $4.86M | Sell |
50,084
-555,511
| -92% | -$53.9M | ﹤0.01% | 861 |
|
2018
Q2 | $57M | Sell |
605,595
-235,479
| -28% | -$22.2M | 0.06% | 333 |
|
2018
Q1 | $68.2M | Sell |
841,074
-79,688
| -9% | -$6.46M | 0.07% | 307 |
|
2017
Q4 | $82.1M | Buy |
920,762
+305,900
| +50% | +$27.3M | 0.08% | 289 |
|
2017
Q3 | $57.2M | Buy |
614,862
+241,183
| +65% | +$22.4M | 0.06% | 354 |
|
2017
Q2 | $33.9M | Sell |
373,679
-5,948
| -2% | -$540K | 0.04% | 424 |
|
2017
Q1 | $33.3M | Sell |
379,627
-12,208
| -3% | -$1.07M | 0.03% | 437 |
|
2016
Q4 | $32.5M | Sell |
391,835
-105,580
| -21% | -$8.75M | 0.04% | 444 |
|
2016
Q3 | $46M | Sell |
497,415
-191,707
| -28% | -$17.7M | 0.05% | 375 |
|
2016
Q2 | $53.6M | Sell |
689,122
-307,976
| -31% | -$24M | 0.06% | 351 |
|
2016
Q1 | $82.2M | Buy |
997,098
+123,215
| +14% | +$10.2M | 0.1% | 283 |
|
2015
Q4 | $91.5M | Buy |
873,883
+388,360
| +80% | +$40.7M | 0.11% | 259 |
|
2015
Q3 | $51.1M | Buy |
+485,523
| New | +$51.1M | 0.06% | 364 |
|
2015
Q1 | – | Sell |
-511,856
| Closed | -$46.3M | – | 1362 |
|
2014
Q4 | $46.3M | Sell |
511,856
-135,330
| -21% | -$12.2M | 0.05% | 400 |
|
2014
Q3 | $46.7M | Buy |
647,186
+23,727
| +4% | +$1.71M | 0.05% | 369 |
|
2014
Q2 | $38.8M | Sell |
623,459
-218,100
| -26% | -$13.6M | 0.04% | 419 |
|
2014
Q1 | $57.4M | Buy |
841,559
+147,649
| +21% | +$10.1M | 0.07% | 338 |
|
2013
Q4 | $48.8M | Buy |
+693,910
| New | +$48.8M | 0.06% | 354 |
|